Relationship of lipoprotein(a) with intimal medial thickness of the carotid artery in Type 2 diabetic patients in south India

Diabetic Medicine

Volumn 20, Issue 6, 2003, Pages 455-461

  Velmurugan, K ^a   Deepa, R ^a   Ravikumar, R ^a   Lawrence, J B ^a   Anshoo, H ^a   Senthilvelmurugan, M ^a   Enas, E A ^b   Mohan, V ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b Coronary Artery Dis Among Asian I ^*  (United States)

Author keywords

Carotid atherosclerosis; Intimal medial thickness; Lipoprotein(a)

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INDIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; BLOOD PRESSURE; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN A; HUMANS; INDIA; LIPOPROTEIN(A); MALE; MIDDLE AGED; PREVALENCE; TIME FACTORS;

EID: 0037783911     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00976.x     Document Type: Article

References (59)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
2. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596-601.
3. McKeigue PM, Miller GJ, Marmot MG. Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol 1989; 42: 597-609.
4. Anand S, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000; 356: 279-284.
5. Mohan V, Deepa R, Shanthi Rani S, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India. The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 2001; 38: 682-687.
6. Mohan V, Ravikumar R, Shanthi Rani S, Deepa R. Intimal medial thickness of the carotid artery in South Indian diabetic and non-diabetic subjects: the Chennai Urban Population Study (CUPS). Diabetologia 2000; 43: 494-499.
7. Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 1995; 345: 405-409.
8. Anand S, Enas EA, Pogue J, Haffner S, Pearson T, Yusuf S. Elevated lipoprotein (a) levels in South Asians in North America. Metabolism 1998; 47: 182-184.
9. Enas EA. Lipoprotein (a) is an important genetic risk factor for coronary artery disease in Asian Indians. Am J Cardiol 2001; 88: 201-202.
10. Low PS, Heng C, Saha N, Tay J. Racial variation of cord plasma lipoprotein (a) levels in relation to coronary risk level: a study in three ethnic groups in Singapore. Pediatr Res 1996; 40: 718-722.
11. Mohan V, Deepa R, Haranath S, Premlatha G, Rema M, Sastry N, Enas EA. Lipoprotein (a) is an independent risk factor for coronary artery disease in NIDDM patients in South India. Diabetes Care 1998; 21: 1819-1823.
12. Deepa R, Anjana M, Rema M, Haranath SP, Saravanan G, Mohan V. Lipoprotein (a) in south Indian Type 2 diabetic subjects in relation to diabetic vascular complications. J Assoc Phys India 2001; 50: 657-661.
13. Morrisett JD. The role of lipoprotein[a] in atherosclerosis. Curr Atheroscler Rep 2000; 2: 243-250.
14. Dahlen CG. Lipoprotein (a) in cardiovascular disease: review article and viewpoint. Atherosclerosis 1994; 108: 111-126.
15. Sandkamp M, Funke H, Schulte H, Kohler E, Assman G. Lipoprotein (a) is an independent risk factor for myocardial infarction at young age. Clin Chem 1990; 36: 20-23.
16. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996; 77: 1179-1184.
17. Hoeffler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM. Lipoprotein Lp (a) - a risk factor for myocardial infarction. Arteriosclerosis 1988; 8: 398-401.
18. Zenker G, Koltringer P, Bone G, Niederkorn K, Pfiefer K, Jurgens G. Lipoprotein (a) as a strong risk factor for cerebrovascular disease. Stroke 1986; 17: 942-945.
19. Seed M, Ayres KL, Humphries SE, Miller GJ. Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men. Am J Med 2001; 110: 22-27.
20. Nagayama M, Shinohara Y, Nagayama T. Lipoprotein (a) and ischemic cerebrovascular disease in young adults. Stroke 1994; 25: 74-78.
21. Woo J, Lau E, Lam C, Kay R, Teoh R, Wong H et al. Hypertension lipoprotein (a) and apolipoprotein A-1 as risk factors for stroke in the Chinese. Stroke 1991; 22: 203-208.
22. Gupta R, Kastia S, Rastogi S, Kaul V, Nagar R, Enas EA. Lipoprotein (a) in coronary heart disease: a case-control study. Indian Heart J 2000; 52: 407-410.
23. Budde T, Fechtrup C, Bosenberg E, Vielhauer C, Enbergs A, Schulte H et al. Plasma Lp (a) levels correlate with the number, severity and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb 1994; 14: 1730-1736.
24. Superko HR, Hecht HS. Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification. Am J Cardiol 2001; 88: 260-264.
25. Durrington PN, Ishola M, Hunt L, Arrol S, Bhatnagar D. Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease. Lancet 1988; 1: 1070-1073.
26. Hoff HF, Beck GJ, Skibinski CI, Jurgens G, O'Neil J, Kramer J et al. Serum Lp (a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988; 77: 1238-1244.
27. Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G. Apolipoprotein (a) phenotypes, Lp (a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo (a) gene in coronary heart disease. J Clin Invest 1992; 89: 1040-1046.
28. Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS. Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study. Circulation 1991; 84: 160-167.
29. Schreiner PJ, Heiss G, Tyroler HA, Morrisett JD, Davis CE, Smith R. Race and gender differences in the association of Lp (a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 1996; 16: 471-478.
30. Baldassarre D, Tremoli E, Franceschini G, Michelagnoli S, Sirtori CR. Plasma lipoprotein (a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke 1996; 27: 1044-1049.
31. Schriner PJ, Morriset J, Sharret AR, Patsch W, Tyroler HA, Wu K et al. Lipoprotein (a) as a risk factor for preclinical atherosclerosis. Arterioscler Thromb 1993; 13: 826-833.
32. Cambillau M, Simon A, Amar J, Giral P, Atger V, Segond P et al. Serum Lp (a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group. Arterioscler Thromb 1992; 12: 1346-1352.
33. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
34. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kajimoto Y et al. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 1994; 43: 634-639.
35. Lonn EM, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S et al. Effects of ramipril and vitamin E on atherosclerosis: The study to Evaluate Carotid Ultrasound changes in Patients Treated With Ramipril and Vitamin E (SECURE). Circulation 2001; 103: 919-925.
36. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
37. Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H et al. Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 1992; 15: 1290-1294.
38. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report (JNC VI). Arch Intern Med 1997; 157: 2413-2446.
39. NCEP. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
40. von Eckardstein A, Schulte H, Cullen P, Assmann G. Lipoprotein (a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol 2001; 37: 434-439.
41. Hoogeveen RC, Gambhir JK, Gambhir DS, Kimball KT, Ghazzaly K, Gaubatz JW et al. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res 2001; 42: 631-638.
42. Schreiner PJ. Lipoprotein (a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: the Atherosclerosis Risk in Communities (ARIC) Study. Chem Phys Lipids 1994; 67-68: 405-410.
43. Markus HS, Kapadia R, Sherwood RA. Relationship between lipoprotein (a) and both stroke and carotid atheroma. Ann Clin Biochem 1997; 34: 360-365.
44. Cao H, Girard-Globa A, Serusclat A, Bernard S, Bondon P, Picard S et al. Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus. Atherosclerosis 1998; 138: 361-366.
45. Raitakari OT, Adams MR, Celermajer DS. Effect of Lp (a) on the early functional and structural changes of atherosclerosis. Arterioscler Thromb Vasc Biol 1999; 19: 990-995.
46. Jurgens G, Koltringer P. Cerebrovascular disease and Lp (a): its role in atherosclerotic plaque formation and vessel wall elasticity of the carotid arteries. Chem Phys Lipids 1994; 67/68: 429-439.
47. Yamamoto M, Egusa G, Yamakido M. Carotid atherosclerosis and serum lipoprotein (a) concentrations in patients with NIDDM. Diabetes Care 1997; 20: 829-831.
48. Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993; 13: 1558-1566.
49. Kronenberg F, Trenkwalder E, Dieplinger H, Utermann G. Lipoprotein (a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail. Arterioscler Thromb Vasc Biol 1996; 16: 1568-1572.
50. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146: 483-494.
51. Schreiner PJ, Chambless L, Brown S, Watson RL, Toole J, Heiss G. Lipoprotein (a) as a correlate of stroke and transient ischemic attack prevelance in a biracial cohort: the ARIC Study. Ann Epidemiol 1994; 4: 351-359.
52. Schreiner PJ, Chambless L, Folsom A, Rosamond W, Cooper L, Morrisett J. Lipoprotein[a] and incident ischemic stroke: the ARIC study. Circulation 1998; 97: 818.
53. Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger G, Jarosch E et al. Lipoprotein (a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck study. Stroke 1995; 26: 1582-1587.
54. Brown SA, Hutchinson R, Morrisett J, Boerwinkle E, Davis CE, Gotto AM Jr et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993; 13: 1139-1158.
55. Moliterno DJ, Jokinen EV, Miserez AR, Lange RA, Willard JE, Boerwinkle E et al. No association between plasma lipoprotein (a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler Thromb Vasc Biol 1995; 15: 850-855.
56. Hughes K, Aw TC, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein (a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health 1997; 51: 394-399.
57. Tato F, Keller C, Schuster H, Spengel F, Wolfram G, Zollner N. Relation of lipoprotein (a) to coronary heart disease and duplexsonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia. Atherosclerosis 1993; 101: 69-77.
58. Kronenberg F, Trenkwalder E, Sturm W, Kathrein H, Konig P, Neyer U et al. LDL-unbound apolipoprotein (a) and carotid atherosclerosis in hemodialysis patients. Clin Genet 1997; 52: 377-386.
59. Dionyssiou-Asteriou A, Papastamatiou M, Vatalas I, Bastounis E. Serum Lp (a) lipoprotein levels in patients with atherosclerotic occlusive disease of the lower extremities. Eur J Vasc Endovasc Surg 2000; 20: 57-60.